Results 251 to 260 of about 223,220 (289)
Some of the next articles are maybe not open access.
MicroRNA in non-melanoma skin cancer
Cancer Biomarkers, 2012MicroRNAs (miRNAs) are a fairly novel class of 17- to 23-nucleotide (nt), short, non-coding RNA molecules that have revolutionized our understanding of gene regulation and opened new possibilities in the future of gene therapy. Here, we review the potential role of miRNAs in non-melanoma skin cancer (NMSC) and summarize the current studies available in
Michael, Sand +3 more
openaire +2 more sources
Photodynamic Therapy For Non-Melanoma Skin Cancers
Current Cancer Therapy Reviews, 2009Photodynamic therapy (PDT) consists of topical or systemic delivery of photosensitizing drugs followed by ir- radiation with light. Topical PDT is currently carried out with 5-aminolaevulinic acid (ALA) or methylaminolaevulinate (MAL) both metabolized in the cells to protoporphyrinIX (PpIX), a photosensitizing molecule absorbing visible light.
MONFRECOLA, GIUSEPPE +2 more
openaire +3 more sources
Non-melanoma Skin Cancer in Canada Chapter 2: Primary Prevention of Non-melanoma Skin Cancer
Journal of Cutaneous Medicine and Surgery, 2015Background Non-melanoma skin cancer (NMSC), including basal and squamous cell carcinoma (BCC and SCC), represents the most common malignancy. Objective To provide guidance to Canadian health care practitioners regarding primary prevention of NMSC. Methods Structured literature searches were conducted, using search terms including prevention, sunscreen,
Kirk, Barber +4 more
openaire +2 more sources
1997
Non-melanoma skin cancers (NMSC) comprised of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the most common human cancers [14,24,25]. The annual incidence of NMSC is rapidly increasing, with an average increase between 3% and 6% per year in most populations, and has been reported to be almost 1000 per 100000 people in Australia [1 ...
openaire +1 more source
Non-melanoma skin cancers (NMSC) comprised of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the most common human cancers [14,24,25]. The annual incidence of NMSC is rapidly increasing, with an average increase between 3% and 6% per year in most populations, and has been reported to be almost 1000 per 100000 people in Australia [1 ...
openaire +1 more source
Prevention of non-melanoma skin cancer
Current Oncology Reports, 2001Basal cell and squamous cell carcinomas comprise the majority of non-melanoma skin cancers. Whereas the incidence of skin cancer is equivalent to that of all other cancers combined, non-melanoma skin cancer receives a disproportionate share of attention because mortality is relatively low. However, the impact on public health is striking.
openaire +2 more sources
Management of Non-melanoma Skin Cancer
Seminars in Oncology Nursing, 2013To review types of, and treatment for, non-melanoma skin cancer (NMSC): basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and less common NMSC.Standards of care, dermatology texts, peer-reviewed journals.BCC grows slowly and rarely metastasizes; some BCC subtypes can be aggressive and destructive.
openaire +3 more sources
2005
Skin cancer is currently of interest because of the increasing incidence of tumors diagnosed by dermatologists. Because these cancers are not generally reported in tumor registries, the numbers are likely to be underestimated. About 600,000 new cases, representing one third of all new cancers, are diagnosed annually in the USA (reviewed in Corona, 1996)
openaire +1 more source
Skin cancer is currently of interest because of the increasing incidence of tumors diagnosed by dermatologists. Because these cancers are not generally reported in tumor registries, the numbers are likely to be underestimated. About 600,000 new cases, representing one third of all new cancers, are diagnosed annually in the USA (reviewed in Corona, 1996)
openaire +1 more source